Cargando…
Should I take aspirin? A qualitative study on the implementation of a decision aid on taking aspirin for bowel cancer prevention
OBJECTIVES: Australian guidelines recommend 50–70 years consider taking aspirin to reduce their bowel cancer risk. We trialled a decision aid in general practice to facilitate the implementation of these guidelines into clinical practice. This publication reports on the qualitative results from the...
Autores principales: | Onwuka, Shakira, McIntosh, Jennifer, Boyd, Lucy, Karnchanachari, Napin, Macrae, Finlay, Fishman, George, Emery, Jon |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10689404/ https://www.ncbi.nlm.nih.gov/pubmed/38035774 http://dx.doi.org/10.1136/fmch-2023-002423 |
Ejemplares similares
-
An RCT of a decision aid to support informed choices about taking aspirin to prevent colorectal cancer and other chronic diseases: a study protocol for the SITA (Should I Take Aspirin?) trial
por: Milton, Shakira, et al.
Publicado: (2021) -
Clinicians’ opinions on recommending aspirin to prevent colorectal cancer to Australians aged 50–70 years: a qualitative study
por: Milton, Shakira, et al.
Publicado: (2021) -
Commentary: Pivoting during a pandemic: developing a new recruitment model for a randomised controlled trial in response to COVID-19
por: Milton, Shakira, et al.
Publicado: (2021) -
Which people should take aspirin for primary prevention of cardiovascular disease?
por: Lozano, Roberto, et al.
Publicado: (2015) -
Hemorrhagic Cholecystitis in an Elderly Patient Taking Aspirin and Cilostazol
por: Morris, David S., et al.
Publicado: (2008)